ArtBlood, a biotechnology company specializing in transfusion blood production, announced that it has signed a Memorandum of Understanding (MOU) with Expression Manufacturing LLC ("Expression"), the manufacturing subsidiary of Expression Therapeutics, Inc., to collaborate on the clinical development and large-scale production of in vitro-produced blood.
News
ArtBlood Signs MOU with Expression Manufacturing for Large-Scale In Vitro Red Blood Cell Production in Ohio
Published: April 08, 2025
Related Articles
Business Climate
Central Ohio is a growing U.S. biotech hub, national trade group leader says
Read More
(external link)
Business Climate
Innovation Districts Increasingly Drawn To Water
Read More
(external link)
Business Climate
Cleveland Clinic’s $1.3 billion expansion is just the beginning
Read More
(external link)